ENTRY       D00539                      Drug
NAME        Ethosuximide (JP18/USP/INN);
            Zarontin (TN)
PRODUCT     ZARONTIN (Parke-Davis Div of Pfizer)
  GENERIC   ETHOSUXIMIDE (Akorn)
            ETHOSUXIMIDE (Bionpharma)
            ETHOSUXIMIDE (Bryant Ranch Prepack)
            ETHOSUXIMIDE (Epic Pharma)
            ETHOSUXIMIDE (Epic Pharma)
            ETHOSUXIMIDE (Greenstone LLC)
            ETHOSUXIMIDE (Greenstone LLC)
            ETHOSUXIMIDE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            ETHOSUXIMIDE (PAI Holdings)
            ETHOSUXIMIDE (Strides Pharma Science Limited)
            ZARONTIN (Parke-Davis Div of Pfizer)
FORMULA     C7H11NO2
EXACT_MASS  141.079
MOL_WEIGHT  141.1677
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01573  Calcium channel T type blocker
            Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02033  Succinimide antiepileptic
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07505
            Therapeutic category: 1139
            ATC code: N03AD01
            Product: D00539<JP/US>
EFFICACY    Antiepileptic
COMMENT     Succinimide derivative
TARGET      CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
  PATHWAY   hsa04010(8911+8912+8913)  MAPK signaling pathway
            hsa04020(8911+8912+8913)  Calcium signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07033  Anticonvulsants
            map07036  Calcium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AD Succinimide derivatives
                 N03AD01 Ethosuximide
                  D00539  Ethosuximide (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Calcium Channel Modifying Agents
               Ethosuximide
                D00539  Ethosuximide (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1139  Others
                 D00539  Ethosuximide (JP18/USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                D00539  Ethosuximide
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02033  Succinimide antiepileptic
                D00539  Ethosuximide
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00539  Ethosuximide
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00539  Ethosuximide
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-T
                 D00539  Ethosuximide (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00539  Ethosuximide
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00539
DBLINKS     CAS: 77-67-8
            PubChem: 7847605
            ChEBI: 4887
            LigandBox: D00539
            NIKKAJI: J1.477J
ATOM        10
            1   C1z C    30.2572  -15.7833
            2   C5x C    31.0718  -14.6371
            3   C1x C    28.9189  -15.3703
            4   C1b C    31.5607  -16.2779
            5   C1a C    29.4311  -16.9121
            6   N1x N    30.2341  -13.5199
            7   O5x O    32.4683  -14.6255
            8   C5x C    28.9016  -13.9681
            9   C1a C    31.5774  -17.6569
            10  O5x O    27.7611  -13.1534
BOND        10
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     2   6 1
            6     2   7 2
            7     3   8 1
            8     4   9 1
            9     8  10 2
            10    6   8 1
///
